| November 19, 2009 | Faster News for Faster Cures |
 |  |
| Top News |  |  |
|
- More drug firms invest in vaccine R&D
Vaccines are catching up with prescription drugs as the most lucrative segment of the pharmaceutical business, as more biotech and drug firms invest in vaccine development. GlaxoSmithKline opened a vaccine-packaging plant in Pennsylvania in a bid to topple Merck & Co. as a global leader in vaccine manufacturing, while Johnson & Johnson plans to build a full vaccine portfolio that includes a universal flu shot and a vaccine for Alzheimer's disease. Google/The Associated Press
(11/18)
    
| News from FasterCures | | |
|
-
Partnering for Cures, Dec. 1 to 3, New York City
In two weeks, hundreds of medical research leaders, funders and decision-makers will convene at the inaugural Partnering for Cures meeting to explore innovative approaches to pursuing high-risk, long-term investments that could lead to medical breakthroughs. Join us in New York City on Dec. 1 to 3 and help catalyze a more effective and efficient medical research enterprise.- Program schedule features more than 75 confirmed speakers from philanthropy, foundations, industry, academia, government and media
- Speakers include Pfizer's Jeffrey Kindler, FDA's Joshua Sharfstein, PhRMA's Billy Tauzin, Harvard Medical School's Levi Garraway, Merck's Greg Wiederrecht, NIAID's Anthony Fauci, Eli Lilly & Company's Gail Cassell
- Presentations from 42 nonprofit foundations featuring their capabilities and research and development strategies
- Opportunities to connect with potential partners and funders through an effective partnering system, therapeutic affinity roundtables and networking events.
 |
| Science and Technology | | |
|
- Scientists develop silicon-based chip for diagnosing diseases
Swiss scientists have developed a silicon-based chip that can show disease markers in the blood when placed under light. The device is cost-effective, needs only a small amount of blood to be able to diagnose diseases and gives out results in minutes, the researchers said. "We are giving back precious minutes to doctors so they can make informed and accurate decisions right at the time they need them most to save lives," a researcher said. BBC
(11/18)
- Imaging apoptosis could help determine cancer treatment efficacy
Researchers are developing a targeted contrast agent that will allow for the imaging of tumor cell death through spectroscopy and nuclear magnetic resonance. Imaging apoptotic cells could help determine whether cancer treatments are effective and direct drug development and treatment management, the researchers said. HealthImaging.com
(11/18)
| Finance and Economics | | |
|
- Ignite Institute plans center for genetic research
The Ignite Institute for Individualized Health plans to set up a 300,000-square-foot genetic research center in Fairfax County, Va., that would bring in 415 jobs in the next five years and would collaborate with Inova Health System, said Dietrich Stephan, the nonprofit group's founder and geneticist. Research at the $200 million facility is expected to focus on personalized medicine. The Washington Post
(11/17)
- EraGen, Illumina partner on genetic test technologies
EraGen Biosciences, a maker of molecular diagnostic tests for infectious diseases, has agreed to partner and signed nonexclusive licensing deals with Illumina that will enable it to further develop its genetic tests using some of Illumina's technologies. Eragen said it expects the partnership to broaden its product portfolio. Milwaukee Journal Sentinel
(11/18)
| Law and Regulation | | |
|
- Senate unveils health care reform bill
The Congressional Budget Office said the Senate's health care bill would cut the U.S. budget deficit by about $130 billion in its first 10 years. The measure presented by Senate Majority Leader Harry Reid, D-Nev., would extend coverage to 31 million Americans but would also delay the rollout of the new program to 2014. The first test of the measure's fate in the Senate will come in a procedural vote expected on Friday or Saturday, when Reid will need 60 votes to overcome Republican opposition and begin debate. The Washington Post
(11/19)
, The Wall Street Journal
(11/19)
, The New York Times
(11/18)
- Green chosen as director of NIH genome research institute
The NIH's National Human Genome Research Institute has chosen Dr. Eric Green, a research scientist and former scientific director of the institute, to serve as director, effective Dec. 1. "My job going forward is to ... find effective ways to collaborate with a wide range of researchers to translate genomic discoveries into medical advances," Green said. St. Louis Post-Dispatch
(11/19)
| |
| FasterCures is dedicated to saving lives by saving time. We will
identify and implement global solutions to accelerate the
process of discovery and clinical development of new therapies
for the treatment of deadly and debilitating diseases. In
support of this vision, we will study and act on issues within
the following four arenas: Science and Technology, Law and
Regulation, Economics and Finance, and Society and Ethics.
|
| Contact Us |
FasterCures / The Center for Accelerating Medical Solutions
1101 New York Avenue, NW
Suite 620
Washington, DC 20005
202.336.8900 |
www.fastercures.org |
| |
|
| |
| |
| | Recent FasterCures SmartBrief Issues:
- Tuesday, November 17, 2009
- Thursday, November 12, 2009
- Tuesday, November 10, 2009
- Thursday, November 05, 2009
- Tuesday, November 03, 2009
| | | Lead Editor: Ashley McMaster
Distributed by:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005 | |
| |
|
| © 1999-2009 SmartBrief, Inc.® Legal Information |
|
